In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Dompe's Private Power

Executive Summary

Milan's Dompé Biotec is arguably Italy's leading marketer of biotechnology products. The wholly-owned subsidiary of Dompé Farmaceutici SPA gained access to three early products of biotechnology by allying with the large multinational firms that held European rights to them. But the privately held Italian firm has since made a point of directly pursuing American biotech companies, because they have what it wants: innovative treatments for specific medical conditions. But even the most carefully considered in-licensing deals won't help Dompé grow as fast as its owners would like. The firm, now intent on expanding its reach beyond Italy, hopes its past marketing experience will attract new partners.

You may also be interested in...



Q1 Recalls Snapshot: 355 Million+ Device Units Recalled In First Quarter Of 2020, A Jump Of 530%

An enormous recall of more than 314 million device units proved to be a headache for industry in the first quarter of 2020. But on a slightly brighter note, manufacturers initiated 260 recalls in the first quarter, a 6% decline from 2019’s fourth quarter tally of 277. Check out our Q1 recalls infographic.

Acutus Medical Inks Marketing Deal With Biotronik; Mapping Its Way To Electrophysiologists Outside US

Biotronik will help Acutus to bring its cardiac mapping software and guidance system to electrophysiologists worldwide.

Manufacturers Should Map Processes, Bolster Quality Culture To Tackle Data Integrity Problems in The Microbiology Lab

To reduce the opportunity for data integrity failures in the microbiology lab, manufacturers should map out the workflow so that activities and expectations for employees are clearly spelled out. Having formalized processes will ensure that employees don’t cut corners.

Topics

Related Companies

Related Deals

UsernamePublicRestriction

Register

LL1123310

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel